4//SEC Filing
Aminov Erez 4
Accession 0001493152-24-022029
CIK 0001904286other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 6:00 PM ET
Size
6.9 KB
Accession
0001493152-24-022029
Insider Transaction Report
Form 4
Aminov Erez
DirectorChief Executive Officer
Transactions
- Award
Incentive Stock Options (right to buy)
2024-05-28+379,000→ 629,000 totalExercise: $0.84Exp: 2034-05-28→ Common Stock (379,000 underlying)
Footnotes (3)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on May 28, 2024.
- [F2]The stock options were issued to the Reporting Person on May 28, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). The stock options vested in full and became exercisable immediately upon issuance on the grant date, May 28, 2024.
- [F3]Represents 50,000 stock options that were issued to the Reporting Person on April 28, 2023 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $5.00 each, (ii) 150,000 stock options that were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each, (iii) 50,000 stock options that were issued to the Reporting Person on August 17, 2023 that vested in full and became exercisable on April 28, 2024, pursuant to a grant under the Issuer's Plan at an exercise price of $6.50 each, and (iv) 379,000 stock options that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $0.84 each.
Documents
Issuer
MIRA PHARMACEUTICALS, INC.
CIK 0001904286
Entity typeother
Related Parties
1- filerCIK 0001986112
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 6:00 PM ET
- Size
- 6.9 KB